One aspect of the recent sensational events regarding Valeant Pharmaceuticals International provides a strong debating point over the governance of externally managed listed investment companies, with real relevance in Australia. Might be time to re-examine the prospectuses you subscribed to in the last two years.



Comments

Please sign in to comment on this wire.